Group items matching

in title, tags, annotations or url

This announcement solicits applications for Early Detection of Vision Problems in Young Children. The purpose of this grant program is to increase the detection and diagnosis of visual impairment in children aged five (5) years and younger in five (5) States by enhancing the capacity of the State public health agencies to use and apply quality improvement principles and practices to implement universal Vision screening for preschool-aged children. Funds will be provided to a single entity to convene a learning collaborative comprised of five States to work together jointly to identify challenges, interventions, implementation, and measurement related to implementing universal Vision screening for preschool-aged children. To facilitate collaborative learning and quality improvement efforts, the awardee may ask each of the five participating States to consider forming a Vision screening quality improvement team. The optimal team would include representatives from the State Title V program, State early childhood and education programs, State health surveillance and information systems (e.g., immunization registry), community health centers, pediatric primary and Vision specialty care, and family organizations. The awardee may convene the State teams to apply rapid test cycles to increase coordination among the relevant State agencies, providers, and community organizations to support the tracking, disseminating, and spreading of innovative and promising practices necessary to achieve the program purpose. Program Aim: By 2018, increase by 20 percent over 2011-2012 levels, the proportion of children aged five (5) years and younger who receive Vision screening and diagnosis in five (5) States according to the National Survey of Children¿s Health measure. http://www.childhealthdata.org/learn/NSCH To accomplish the program purpose and aim, it is expected the awardee will: · Establish a multidisciplinary project advisory group made up of stakeholders includin

The purpose of the RERC program is to improve the effectiveness of services authorized under the Rehabilitation Act by conducting advanced engineering research on and development of innovative technologies that are designed to solve particular rehabilitation problems or to remove environmental barriers. RERCs also demonstrate and evaluate such technologies, facilitate service delivery system changes, stimulate the production and distribution of new technologies and equipment in the private sector, and provide training opportunities. RERC on Low Vision and Blindness: NIDILRR seeks to fund an RERC on low Vision and blindness to research, develop, and evaluate innovative technologies that will improve the ability of individuals with low Vision and blindness to function independently within their schools, communities, and workplaces. This RERC must research and develop technologies that will promote independence for individuals with low Vision and blindness of all ages, including those who are deaf-blind and those with multiple disabilities.

To advance this mission, the foundation awards grants of up to $5,000 in support of research on the elimination of ocular diseases causing vision loss and suffering in animals. Grant awards support the purchase of research supplies, materials, equipment (limited);, publication costs; and salary for technical support. Grant awards do not support the salary of the resident, the salary of the faculty mentor, tuition costs, major equipment purchases, or institutional indirect costs.

The purpose of this Funding Opportunity Announcement (FOA) is to establish a joint initiative between the National Eye Institute (NEI) and the Vision Research Program (Vision Research Program) of the Department of Defense (DOD). Through this FOA, the NEI will support meritorious VRP proposals that were unable to be funded by the DOD.

VISION RESEARCH SCIENTIFIC FORUM FEATURING RECIPIENTS OF THE 2019 PREVENT BLINDNESS YOUNG INVESTIGATOR STUDENT FELLOWSHIP AWARDS FOR FEMALE SCHOLARS IN VISION RESEARCH: - Naseem Amirmokhtari - Northeast Ohio Medical University - Gabrielle Frame - Northeast Ohio Medical University - Phuong Thai Lam - Miami University Keynote Speaker: Fatoumata Yanoga, MD, The Ohio State University, Department of Ophthalmology and Visual Sciences

The Prevent Blindness Ohio Young Investigator Student Fellowship Awards for Female Scholars in Vision Research provides training support for future generations of outstanding female scientists committed to pursuing biomedical, behavioral or clinical research careers relevant to the mission of Prevent Blindness Ohio - to prevent blindness and preserve sight.  The fellowship awards provide partial support to younger investigators, promoting the development of scientific skills that will lead to more substantial funding from other sources.

Prevent Blindness Ohio is accepting applications for its 2014 Young Investigator Student Fellowship Awards for Female Scholars in Vision Research. The Fellowship Program is designed to provide support for outstanding female scientists committed to pursuing biomedical, behavioral or clinical research careers relevant to the mission of Prevent Blindness Ohio - to prevent blindness and preserve sight. 

The Anesthesia Patient Safety Foundation (APSF) Grant Program supports research directed towards enhancing anesthesia patient safety.  The Program's objective is to stimulate and fund studies that will clearly improve patient safety and lead to prevention of mortality and morbidity resulting from anesthesia mishaps.  The APSF vision and mission statements help guide this process. The APSF's vision statement is that no patient shall be harmed by anesthesia and the mission is to improve the safety of patients during anesthesia care by encouraging and conducting: safety research and education; patient safety programs and campaigns; and national and international exchange of information and ideas.

The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the "best and brightest" in their field(s) through extraordinary creativity, vision, leadership, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and should exhibit strong potential for future leadership in the breast cancer research community. As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the applicant's demonstrated ability to go beyond conventional thinking in their field and the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer. The PI should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of his/her full-time professional effort during the award period to breast cancer research. This professional effort in breast cancer research can be through a combination of this award and other current support. Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit. The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PI's research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization.

The purpose of this notice of funding opportunity is to identify and implement innovative strategies to better engage, detect, and manage glaucoma and other eye diseases among vulnerable populations, in community-based settings, for replication and scaling in the US. This NOFO will be accomplished with two components; Component A: Community-Based Interventions with Vulnerable Populations and Component B: Coordinating Center to provide logistics and support to the research study. Glaucoma is the leading cause of irreversible blindness among African Americans and the second leading cause of blindness worldwide. An estimated 2.2 to 2.7 million people in the United States have the disease. Due to its asymptomatic nature, half of people with glaucoma are unaware of their condition, increasing the severity of the disease. However, once detected, appropriate treatment and management can slow glaucoma progression and preserve the remaining vision, but cannot restore lost vision. Given the low general population prevalence of glaucoma, broad general population screening appears not to be cost-effective, and the marginal results from glaucoma screenings in high-risk population, it is reasonable to reach out to groups with higher prevalence (African Americans over age 40, Asians, older people [aged 65+ years] especially older Hispanics, those with a family history of glaucoma, and those with diabetes).

he U.S. Congress provides funds to CDC for programmatic support and procurement of vaccines critical to the success of the global initiatives for polio eradication and measles mortality reduction. The purpose of the program is to support the US Government-endorsed Global Polio Eradication Initiative, Global Measles Initiative, and the Global Immunization Vision and Strategy (GIVS) of which UNICEF is a key partner. Other key partners include CDC, World Health Organization (WHO), the Pan American Health Organization (PAHO), Rotary International, American Red Cross, and the UN Foundation. UNICEF, in conjunction with CDC, will provide programmatic assistance and vaccines for supplemental immunization activities (SIAs) in priority countries as well as strengthening of routine immunization delivery systems and capacities in developing countries to achieve globally agreed goals for disease eradication, elimination and reduction. Additionally this agreement may be used to support activities to address other global health priorities in line with CDC goals. Under this agreement, UNICEF will collaborate with CDC, World Health Organization (WHO), Rotary International, other partner agencies and national governments, for implementation of strategies to achieve the globally agreed goals of polio eradication, measles mortality reduction and elimination, and control of other vaccine preventable diseases (VPD), including identification and prioritization of country vaccine and programmatic assistance needs.

he U.S. Congress provides funds to CDC for programmatic support and procurement of vaccines critical to the success of the global initiatives for polio eradication and measles mortality reduction. The purpose of the program is to support the US Government-endorsed Global Polio Eradication Initiative, Global Measles Initiative, and the Global Immunization Vision and Strategy (GIVS) of which UNICEF is a key partner. Other key partners include CDC, World Health Organization (WHO), the Pan American Health Organization (PAHO), Rotary International, American Red Cross, and the UN Foundation. UNICEF, in conjunction with CDC, will provide programmatic assistance and vaccines for supplemental immunization activities (SIAs) in priority countries as well as strengthening of routine immunization delivery systems and capacities in developing countries to achieve globally agreed goals for disease eradication, elimination and reduction. Additionally this agreement may be used to support activities to address other global health priorities in line with CDC goals. Under this agreement, UNICEF will collaborate with CDC, World Health Organization (WHO), Rotary International, other partner agencies and national governments, for implementation of strategies to achieve the globally agreed goals of polio eradication, measles mortality reduction and elimination, and control of other vaccine preventable diseases (VPD), including identification and prioritization of country vaccine and programmatic assistance needs. 

The goal of the Particulate and Multiphase Processes (PMP) program is to support fundamental research on physico-chemical phenomena that govern particulate and multiphase systems, including flow of suspensions, drops and bubbles, granular and granular-fluid flows, behavior of micro- and nanostructured fluids, and self-assembly/directed-assembly processes that involve particulates.  The program encourages transformative research to improve our basic understanding of particulate and multiphase processes with emphasis on research that demonstrates how particle-scale phenomena affect the behavior and dynamics of larger-scale systems.  Although proposed research should focus on fundamentals, a clear vision is required that anticipates how results could benefit important applications in advanced manufacturing, energy harvesting, transport in biological systems, biotechnology, or environmental sustainability.  Collaborative and interdisciplinary proposals are encouraged, especially those that involve a combination of experiment with theory or modeling.  Proposals whose main focus is on the synthesis of particles are not encouraged.

The goal of the Particulate and Multiphase Processes (PMP) program is to support fundamental research on physico-chemical phenomena that govern particulate and multiphase systems, including flow of suspensions, drops and bubbles, granular and granular-fluid flows, behavior of micro- and nanostructured fluids, and self-assembly/directed-assembly processes that involve particulates.  The program encourages transformative research to improve our basic understanding of particulate and multiphase processes with emphasis on research that demonstrates how particle-scale phenomena affect the behavior and dynamics of larger-scale systems.  Although proposed research should focus on fundamentals, a clear vision is required that anticipates how results could benefit important applications in advanced manufacturing, energy harvesting, transport in biological systems, biotechnology, or environmental sustainability.  Collaborative and interdisciplinary proposals are encouraged, especially those that involve a combination of experiment with theory or modeling.  Proposals whose main focus is on the synthesis of particles are not encouraged.

The goal of the Particulate and Multiphase Processes (PMP) program is to support fundamental research on physico-chemical phenomena that govern particulate and multiphase systems, including flow of suspensions, drops and bubbles, granular and granular-fluid flows, behavior of micro- and nanostructured fluids, and self-assembly/directed-assembly processes that involve particulates.  The program encourages transformative research to improve our basic understanding of particulate and multiphase processes with emphasis on research that demonstrates how particle-scale phenomena affect the behavior and dynamics of larger-scale systems.  Although proposed research should focus on fundamentals, a clear vision is required that anticipates how results could benefit important applications in advanced manufacturing, energy harvesting, transport in biological systems, biotechnology, or environmental sustainability.  Collaborative and interdisciplinary proposals are encouraged, especially those that involve a combination of experiment with theory or modeling.

The goal of the Particulate and Multiphase Processes (PMP) program is to support fundamental research on physico-chemical phenomena that govern particulate and multiphase systems, including flow of suspensions, drops and bubbles, granular and granular-fluid flows, behavior of micro- and nanostructured fluids, and self-assembly/directed-assembly processes that involve particulates.  The program encourages transformative research to improve our basic understanding of particulate and multiphase processes with emphasis on research that demonstrates how particle-scale phenomena affect the behavior and dynamics of larger-scale systems.  Although proposed research should focus on fundamentals, a clear vision is required that anticipates how results could benefit important applications in advanced manufacturing, energy harvesting, transport in biological systems, biotechnology, or environmental sustainability.  Collaborative and interdisciplinary proposals are encouraged, especially those that involve a combination of experiment with theory or modeling.

As "The Army's Sensor Developer," NVESD researches and develops cutting edge technology, with the goal of exceeding U.S. Soldier requirements, and allowing an asymmetrical advantage in changing battlefield environments. This BAA solicits proposals against a broad range of night vision technologies which support the Warfighter and challenges of Asymmetric Warfare. The technologies have been divided into three (3) sections: Science and Technology; Ground Combat Systems; and Modeling and Simulation.

This funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications. Areas of Research Collaboration: Applications are encouraged from organization/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collaborations with Indian investigators on the following: diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, including rare and genetic diseases such as congenital cataracts, as well as other eye conditions such as ocular inflammation/uveitis, refractive error, low vision, and corneal injury. Basic, translational, or epidemiological research maybe proposed. Clinical trials will not be supported under this FOA.

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring. For purposes of this Funding Opportunity Announcement (FOA), the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders, or to compare the effectiveness of two or more established interventions.

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance requiring clear delineation of study organization including roles and responsibilities and careful performance oversight and monitoring. For purposes of this Funding Opportunity Announcement (FOA), the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders, or to compare the effectiveness of two or more established interventions.

The National Science Foundation's (NSF's) Division of Undergraduate Education (DUE) in the Directorate for Education and Human Resources (EHR) acknowledges the need to expand and chronicle educational change efforts across the nation.  To this end, DUE invites proposals to study the impact of the vision and Change (V&C) movement in Undergraduate Biology Education. Specifically, this program seeks to support projects that evaluate a combination of factors such as the awareness, acceptance, adoption, and adaptation of V&C principles and outcomes including changes in curriculum, laboratories, and student retention, completion, and learning. Collectively, results of these projects are anticipated to describe the nature and extent of V&C's use within the undergraduate biology curriculum. The projects could also describe key factors and approaches taken by the V&C community that have the potential to be useful for improving undergraduate education in other scientific disciplines or in interdisciplinary STEM education. 

The mission of BTO is to leverage biology as a technology to solve intractable problems. BTO seeks to leverage advances in engineering and computer science to drive and reshape biotechnology for national security. To achieve this vision, BTO is interested in a range of emerging technical areas, including but not limited to human-machine interfaces, human performance, infectious disease, and synthetic biology. The overarching goal is to develop, demonstrate, and transition biologically-based technologies as part of the national security toolkit.

The goal of the Particulate and Multiphase Processes (PMP) program is to support fundamental research on physico-chemical phenomena that govern particulate and multiphase systems, including flow of suspensions, drops and bubbles, granular and granular-fluid flows, behavior of micro- and nanostructured fluids, and self-assembly/directed-assembly processes that involve particulates. The program encourages transformative research to improve our basic understanding of particulate and multiphase processes with emphasis on research that demonstrates how particle-scale phenomena affect the behavior and dynamics of larger-scale systems. Although proposed research should focus on fundamentals, a clear vision is required that anticipates how results could benefit important applications in advanced manufacturing, energy harvesting, transport in biological systems, biotechnology, or environmental sustainability. Collaborative and interdisciplinary proposals are encouraged, especially those that involve a combination of experiment with theory or modeling.